COPD and Asthma Devices Market to reach $22.8 billion by 2035

COPD and asthma devices market was valued at $12.5 billion in 2025 and is projected to reach $22.8 billion by 2035, growing at a CAGR of 6.3% during the forecast period (2026-2035). The growth of the COPD and asthma devices market is supported by the sustained rise in the clinical burden of chronic respiratory diseases, as reflected in the most recent government and institutional data. According to the World Health Organization, chronic obstructive pulmonary disease remains one of the leading causes of mortality, accounting for approximately 3.23 million deaths annually, with a significant share occurring in low- and middle-income countries. Global Initiative for Chronic Obstructive Lung Disease indicate that more than 390 million individuals are currently living with COPD, reflecting an upward revision from earlier epidemiological estimates due to improved diagnosis and reporting.

Browse the full report description of “COPD and Asthma Devices Market Size, Share & Trends Analysis Report by Product Type (Inhalation Devices, Nebulizers, Airway Clearance Devices, and Positive Airway Pressure (PAP) Devices), by Device Category (Portable Devices and Stationary Devices), by End-User (Hospitals, Homecare Settings, Specialty Respiratory Clinics, and Ambulatory Surgical Centers (ASCs)), Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/copd-and-asthma-devices-market

In addition, the Centers for Disease Control and Prevention (CDC, 2025) reports that approximately 16 million adults in the United States have a confirmed COPD diagnosis, with several million additional cases remaining undiagnosed. Asthma prevalence also remains substantial, with over 25 million individuals affected in the US alone in 2024, according to CDC data. These figures indicate a consistently expanding patient base requiring ongoing respiratory support and device-assisted therapy. The increasing disease burden is further reflected in healthcare utilization patterns, particularly hospital admissions and outpatient management demand. According to the UK Office for Health Improvement and Disparities 2025, hospital admissions related to respiratory diseases, including COPD and asthma, continue to show year-on-year growth, driven by exacerbations and late-stage diagnosis.

Innovation Leaders Transforming the COPD and Asthma Devices Market

The key players in the COPD and asthma devices market include Koninklijke Philips N.V., ResMed Inc., GlaxoSmithKline plc , AstraZeneca PLC, Boehringer Ingelheim International GmbH, among others. These companies are advancing innovation in respiratory care solutions through the development of high-precision drug delivery systems, improved airflow management technologies, and compact, patient-centric device platforms, enabling effective and consistent management of chronic respiratory conditions across clinical and homecare settings while supporting the growing demand for long-term, non-invasive, and digitally integrated treatment solutions.

• In 2026, AstraZeneca PLC reported positive late-stage clinical outcomes for its triple-combination inhaler Breztri Aerosphere, demonstrating improved lung function in asthma patients and supporting potential label expansion.

• In April 2025, Sanofi S.A. advanced its respiratory pipeline with multiple clinical-stage biologics targeting asthma and COPD, including amlitelimab and itepekimab, reflecting increased investment in next-generation therapeutic approaches

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Device Category
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Koninklijke Philips N.V., ResMed Inc., GlaxoSmithKline plc , AstraZeneca PLC, Boehringer Ingelheim International GmbH, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global COPD and Asthma Devices Market Report Segment

By Product Type

• Inhalation Devices
• Nebulizers
• Airway Clearance Devices
• Positive Airway Pressure (PAP) Devices

By Device Category

• Portable Devices
• Stationary Devices

By End-User

• Hospitals
• Homecare Settings
• Specialty Respiratory Clinics
• Ambulatory Surgical Centers (ASCs)

Global COPD and Asthma Devices Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/copd-and-asthma-devices-market